PGGM Investments Purchases 789 Shares of Aflac Incorporated (NYSE:AFL)

PGGM Investments boosted its position in shares of Aflac Incorporated (NYSE:AFL) by 0.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 194,015 shares of the financial services provider’s stock after acquiring an additional 789 shares during the quarter. PGGM Investments’ holdings in Aflac were worth $16,006,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Fortitude Family Office LLC bought a new position in shares of Aflac in the fourth quarter valued at about $25,000. Bruce G. Allen Investments LLC bought a new position in shares of Aflac in the fourth quarter valued at about $32,000. Criterion Capital Advisors LLC bought a new position in shares of Aflac in the fourth quarter valued at about $33,000. Arlington Trust Co LLC bought a new position in shares of Aflac in the fourth quarter valued at about $35,000. Finally, Harvest Fund Management Co. Ltd bought a new position in shares of Aflac in the third quarter valued at about $33,000. 67.44% of the stock is owned by institutional investors.

Aflac Price Performance

Shares of AFL stock traded down $0.12 on Friday, reaching $83.61. The company had a trading volume of 1,839,028 shares, compared to its average volume of 2,169,786. The stock has a market capitalization of $48.11 billion, a PE ratio of 10.79, a price-to-earnings-growth ratio of 2.29 and a beta of 0.91. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33. Aflac Incorporated has a one year low of $64.10 and a one year high of $86.26. The business’s 50-day moving average is $82.69 and its 200 day moving average is $81.77.

Aflac (NYSE:AFL) last posted its earnings results on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). The company had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same period last year, the company posted $1.29 EPS. Equities research analysts forecast that Aflac Incorporated will post 6.41 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on AFL shares. Piper Sandler increased their price objective on shares of Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Friday, April 5th. Morgan Stanley upped their price target on shares of Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a research note on Monday, April 15th. The Goldman Sachs Group upped their price target on shares of Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a research note on Tuesday, January 9th. Raymond James upped their price target on shares of Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Finally, Wells Fargo & Company decreased their price target on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 11th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, Aflac presently has a consensus rating of “Hold” and a consensus price target of $82.15.

Insider Transactions at Aflac

In other news, Director Thomas J. Kenny sold 5,000 shares of the stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the completion of the transaction, the director now owns 17,920 shares of the company’s stock, valued at $1,516,390.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP Albert Riggieri sold 8,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total transaction of $666,720.00. Following the completion of the sale, the senior vice president now owns 32,825 shares of the company’s stock, valued at approximately $2,735,635.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Thomas J. Kenny sold 5,000 shares of Aflac stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the sale, the director now directly owns 17,920 shares of the company’s stock, valued at approximately $1,516,390.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 46,493 shares of company stock valued at $3,765,706. 0.90% of the stock is currently owned by insiders.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.